Login to Your Account

Lawmakers question oversight of 340B drug discount program

By Mari Serebrov
Regulatory Editor

Monday, June 5, 2017

Despite some congressional misgivings about the 340B program, efforts to "repeal and replace" the controversial Affordable Care Act (ACA) have sidestepped the drug discount program, even though the ACA expanded the number of hospitals and other providers that qualify for the mandated manufacturer discounts.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription